2011Mini-Reviews in Medicinal ChemistryRequires access

Two Possibilities How to Increase the Efficacy of Antidotal Treatment of Nerve agent Poisonings

Jiřı́ Kassa, Kamil Musílek, Jana Žďárová Karasová, Kamil Kuča, J Bajgar

Open publisher page 22 citations

Abstract

Highly toxic organophosphorus inhibitors of acetylcholinesterase referred as nerve agents are considered to be among the most dangerous chemical warfare agents. The oximes represent very important part of medical countermeasures of nerve agent poisonings. They are used to reactivate the nerve agent-inhibited acetylcholinesterase. Despite long-term research activities, there is no single, broad-spectrum oxime suitable for the antidotal treatment of poisoning with all organophosphorus agents. There are two approaches how to increase and broaden the effectiveness of antidotal treatment of poisoning with nerve agents - to develop new structural analogues of currently available oximes and/or to combine currently available or newly developed oximes. The review describes the evaluation of the potency of newly developed oximes (especially the oxime K203) or combinations of oximes to reactivate nerve agent-inhibited acetylcholinesterase and to counteract the acute toxicity of nerve agents in comparison with single commonly used oxime (obidoxime, trimedoxime or HI-6). Keywords: Acetylcholinesterase, antidotal treatment, combination of oximes, nerve agents, fluorophosphonates, cyclosarin, organophosphorus insecticides, trimedoxime, oximes, monopyridinium, non-phosphonylated, hydroxyiminomethyl

About this research paper

What this paper is about

Highly toxic organophosphorus inhibitors of acetylcholinesterase referred as nerve agents are considered to be among the most dangerous chemical warfare agents. The oximes represent very important part of medical countermeasures of nerve agent poisonings. They are used to reactivate the nerve agent-inhibited acetylcholinesterase. Despite long-term research activities, there is no single, broad-spectrum oxime suitable for the antidotal treatment of poisoning with all organophosphorus agents. There are two approaches how to increase and broaden the effectiveness of antidotal treatment of poisoning with nerve agents - to develop new structural analogues of currently available oximes and/or to combine currently available or newly developed oximes. The review describes the evaluation of the potency of newly developed oximes (especially the oxime K203) or combinations of oximes to reactivate nerve agent-inhibited acetylcholinesterase and to counteract the acute toxicity of nerve agents in comparison with single commonly used oxime (obidoxime, trimedoxime or HI-6). Keywords: Acetylcholinesterase, antidotal treatment, combination of oximes, nerve agents, fluorophosphonates, cyclosarin, organophosphorus insecticides, trimedoxime, oximes, monopyridinium, non-phosphonylated, hydroxyiminomethyl

Why it matters

OpenAlex reports 22 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Highly toxic organophosphorus inhibitors of acetylcholinesterase referred as nerve agents are considered to be among the most dangerous chemical warfare agents. The oximes represent very important part of medical countermeasures of nerve agent poisonings. They are used to reactivate the nerve agent-inhibited acetylcholinesterase. Despite long-term research activities, there is no single, broad-spectrum oxime suitable for the antidotal treatment of poisoning with all organophosphorus agents. There are two approaches how to increase and broaden the effectiveness of antidotal treatment of poisoning with nerve agents - to develop new structural analogues of currently available oximes and/or to combine currently available or newly developed oximes. The review describes the evaluation of the potency of newly developed oximes (especially the oxime K203) or combinations of oximes to reactivate nerve agent-inhibited acetylcholinesterase and to counteract the acute toxicity of nerve agents in comparison with single commonly used oxime (obidoxime, trimedoxime or HI-6). Keywords: Acetylcholinesterase, antidotal treatment, combination of oximes, nerve agents, fluorophosphonates, cyclosarin, organophosphorus insecticides, trimedoxime, oximes, monopyridinium, non-phosphonylated, hydroxyiminomethyl

Key concepts: Nerve agent, Tabun, Acetylcholinesterase, Oxime, Sarin, Pharmacology, Chemistry, Chemical Warfare Agents

Related papers

Back to paper searchBrowse research topicsOriginal source
Two Possibilities How to Increase the Efficacy of Antidotal Treatment of Nerve agent Poisonings — Research Paper | ScholarLens